Background and aims. The aim of this study is to assess the lipid profile pattern of pediatric overweight and/or obese patients with Non-Alcoholic Fatty Liver Disease (NAFLD) in relation to IDF Consensus Criteria for Metabolic Syndrome (MetS).
Material and Methods. We conducted a cross-sectional preliminary study on 45 consecutive pediatric patients. Overweight or obese children aged from 3 to 18 years were included. Standardized measurement of blood pressure and anthropometric parameters were performed. Biological evaluation included inflammatory status, lipid profile, glycemic profile, full blood count and liver function tests. Abdominal ultrasound was performed in all patients.
Results. Prevalence of MetS was 44.4%. A number of 21 patients (46.7%) had NAFLD. MetS patients had higher risk for NAFLD (OR = 9.5, 95% CI = 2.42-37.24). Also patients with positive familial history of type 2 diabetes had a 6.61 fold higher risk for NAFLD (OR = 6.61, 95% CI = 1.74-25.1). We performed a subgroup analysis in patients under ten years old. Patients under the age of ten which had both NAFLD and MetS met more frequently the hypertriglyceride criterion. After adjusting for age and MetS presence, triglyceride levels independently associated with NAFLD (adjusted R square = 0.46, unstandardized B coefficient = 34.51, 95% CI = 4.01-65.02, p = 0.02).
Conclusion. NAFLD obese patients had higher prevalence of MetS, higher BMI and particular lipid profile pattern. Triglyceride levels independently associated with NAFLD after adjusting for age and MetS presence. According to our findings we suggest early triglyceride testing (even below the age of ten) in selected patients.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. WORLD HEALTH ORGANISATION. GLOBAL STRATEGY ON DIET PHYSICAL ACTIVITY AND HEALTH. http://www.who.int/dietphysicalactivity/childhood/en/ accessed on 27/09/2017.
2. FARAG Y.M. GABALLA MR. Diabesity: an overview of a rising epidemic. Nephrol Dial Transplant. 2011; 26(1):28-35.
3. ZIMMET P. ALBERTI K.G. KAUFMAN F. TAJIMA N. SILINK M. ARSLANIAN S. et al. IDF Consensus group. The metabolic syndrome in children and adolescents – an IDF consensus report. Pediatr Diabetes. 2007; 8(5):299-306.
4. VAJRO P. LENTA S. SOCHA P. DHAWAN A. MCKIERNAN P. BAUMANN U. et al. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr. 2012; 54(5):700-13.
5. DI BONITO P VALERIO G GRUGNI G LICENZIATI MR MAFFEIS C MANCO M et al. CARdiometabolic risk factors in overweight and obese children in ITALY (CARITALY) Study Group. Comparison of non-HDL-cholesterol versus triglyceridesto-HDL-cholesterol ratio in relation to cardiometabolic risk factors and preclinical organ damage in overweight/obese children: the CARITALY study. Nutr Metab Cardiovasc Dis. 2015; 25(5):489-94.
6. VIRANI SS. Non-HDL Cholesterol as a metric of good quality of care: Opportunities and challenges. Coulter SA ed. Texas Heart Institute Journal. 2011; 38(2):160-162.
7. OLIVEIRA A. OLIVEIRA A. OLIVEIRA N. OLIVEIRA A. ALMEIDA M. VENEZA L. et al. Is triglyceride to highdensity lipoprotein cholesterol ratio a surrogates for insulin resistance in youth? Health. 2013; 5 481-485.
8. CENTER FOR DISEASE CONTROL AND PREVENTION https://www.cdc.gov/growthcharts/cdc_charts.htm accessed on 27/09/2017.
9. FERNÁNDEZ JR REDDEN DT PIETROBELLI A ALLISON DB. Waist circumference percentiles in nationally representative samples of African-American European-American and Mexican-American children and adolescents. J Pediatr. 2004; 145(4):439-44.
10. FRISANCHO AR. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr. 1981; 34(11):2540-5.
11. WHO IRIS (INSTITUTIONAL REPOSITORY FOR INFORMATION SHARING) http://apps.who.int/iris/handle/10665/43376 accessed on 27/09/2017.
12. SCHWIMMER JB DUNN W NORMAN GJ PARDEE PE MIDDLETON MS KERKAR N. et al. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology 2010; 138:1357–64.
13. ATABEK ME SELVER EKLIOGLU B AKYÜREK N. Which metabolic syndrome criteria best predict non-alcoholic fatty liver disease in children? Eat Weight Disord. 2014; 19(4):495-501.
14. VOS MB ABRAMS SH BARLOW SE CAPRIO S DANIELS SR KOHLI R. et al. NASPGHAN Clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr. 2017; 64(2):319-334.
15. WEISS R OTVOS JD SINNREICH R MISEREZ AR KARK JD. The triglyceride to high-density lipoprotein-cholesterol ratio in adolescence and subsequent weight gain predict nuclear magnetic resonance-measured lipoprotein subclasses in adulthood. J Pediatr. 2011; 158(1):44-50.
16. SULLIVAN JS LE MT PAN Z RIVARD C LOVE-OSBORNE K ROBBINS K. et al. Oral fructose absorption in obese children with non-alcoholic fatty liver disease. Pediatric obesity. 2015; 10(3):188-195.
17. SONG P YU J WANG M CHANG X WANG J AN L. Prevalence and correlates of suspected nonalcoholic fatty liver disease in Chinese children. Int J Environ Res Public Health. 2017; 27; 14(5).
18. ANDERSON EL HOWE LD JONES HE HIGGINS JP LAWLOR DA FRASER A. The Prevalence of non-alcoholic fatty liver disease in children and adolescents: A systematic review and meta-analysis. PLoS One. 2015; 29; 10(10):e0140908.
19. EXPERT PANEL ON INTEGRATED GUIDELINES FOR CARDIOVASCULAR HEALTH AND RISK REDUCTION IN CHILDREN AND ADOLESCENTS; National Heart Lung and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011; 128 Suppl 5:S213-56.
20. LOOMBA R ABRAHAM M UNALP A WILSON L LAVINE J DOO E. et al. Nonalcoholic steatohepatitis clinical research network. Association between diabetes family history of diabetes and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology. 2012; 56(3):943-51.